Condition: Retinoblastoma · Cancer Survivor · Biological Sibling · Sponsor: Vanderbilt-Ingram Cancer Center
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
This description comes directly from the study's public registry record.
Vanderbilt-Ingram Service for Timely Access · 800-811-8480 · cip@vanderbilt.edu
Always discuss trial participation with your own doctor first.
| Lurie Children's Hospital | Chicago, Illinois, United States | Recruiting |
| University of Illinois, Chicago | Chicago, Illinois, United States | Recruiting |
| University of Minnesoa | Minneapolis, Minnesota, United States | Recruiting |
| Washington School of Medicine at St. Louis | St Louis, Missouri, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Recruiting |
| Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
| Vanderbilt-Ingram Cancer Center | Nashville, Tennessee, United States | Recruiting |
| MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Texas Childeren's Hospital | Houston, Texas, United States | Recruiting |
| Children's Hospital of Wisconsin | Milwaukee, Wisconsin, United States | Recruiting |
| The Hosptial for Sick Children | Toronto, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03932786